News
- Megatrends: CEO’s of LCID, XTMIF, BBIG, and MKTDF Focus on Next Wave of Billion Dollar Market Opportunities in Electric Vehicles, Fintech, Carbon Credit NFTs, And Digital Media
03/21/2022 / 14:41 - GlobeNewswire
-
- NAI Global Announces International Market Trends Report on Commercial Real Estate
03/21/2022 / 14:00 - GlobeNewswire
-
- Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific Session
03/21/2022 / 13:30 - GlobeNewswire
-
- Introducing Lettey, a New App that Leverages the Power of Social Networks to Help Renters Find—and Rent—an Apartment in NYC
03/16/2022 / 13:00 - GlobeNewswire
-
- Trillion Dollar Megatrends: CEOs of Albemarle, ChargePoint, First Energy Metals, and Livent Supplying Battery Metals and Infrastructure for Electric Vehicle Boom
03/15/2022 / 14:24 - GlobeNewswire
-
- Dress for Success San Francisco Honors Groundbreaking “Bay Area Women in Power” Leading the Way to Support Others
03/14/2022 / 19:56 - GlobeNewswire
-
- Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints
03/13/2022 / 22:53 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ericsson, C3.ai, and Rivian and Encourages Investors to Contact the Firm
03/12/2022 / 03:00 - GlobeNewswire
-
- Dress for Success San Francisco Honors Groundbreaking “Bay Area Women in Power” Leading the Way to Support Others
03/10/2022 / 18:43 - GlobeNewswire
-
- Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
03/10/2022 / 14:47 - GlobeNewswire
Real-time